Harvard Management Starts New Position in Shares of Johnson & Johnson

Wall St. Watchdog reveals information regarding Harvard Management Co.’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 3 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $12.936 million.

  • Cephalon Inc. (NASDAQ:CEPH): On 06/30/2011, Harvard Management Co. reported holding 175,000 shares with a market value of $13,982,500. This comprised 1.16% of the total portfolio. On 09/30/2011, Harvard Management Co. reported holding 125,000 shares with a market value of $10,087,500. This comprised 1.1% of the total portfolio. The net change in shares for this position over the two quarters is -50,000. About Company: Cephalon, Inc. is an international biopharmaceutical company that discovers, develops, and markets biopharmaceutical products to treat neurological disorders, pain, and cancer. The Company’s products include a product that treats excessive daytime sleepiness associated with narcolepsy.
  • Allied Healthcare International Inc. (NASDAQ:AHCI): On 06/30/2011, Harvard Management Co. reported holding 0 shares. On 09/30/2011, Harvard Management Co. reported holding 741,749 shares with a market value of $2,848,316. This comprised 0.31% of the total portfolio. The net change in shares for this position over the two quarters is 741,749. About Company: Allied Healthcare International Inc. provides alternate site healthcare services and products. The Company provides nursing services, respiratory and infusion therapies, and home medical equipment. Allied Healthcare provides health care products and services in the United Kingdom through its subsidiary, Allied Healthcare Group Limited, and regionally in the United States.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Harvard Management Co. reported holding 0 shares. On 09/30/2011, Harvard Management Co. reported holding 1,000 shares with a market value of $269. This comprised 0% of the total portfolio. The net change in shares for this position over the two quarters is 1,000. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

(Note: Data regarding Harvard Management Co.’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet